Viewing Study NCT06964568


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-06-30 @ 9:51 PM
Study NCT ID: NCT06964568
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2025-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TDLN-sparing RT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Carcinoma View
None Radiotherapy View
None Immunotherapy View
Keywords: